Glycopyrrolate for sialorrhea in Parkinson disease: A randomized, double-blind, crossover trial

Neurology

Volumn 74, Issue 15, 2010, Pages 1203-1207

  Arbouw, M E L ^a,c,d   Movig, K L L ^a   Koopmann, M ^a   Poels, P J E ^b   Guchelaar, H J ^e   Egberts, T C G ^c,d   Neef, C ^f   Van Vugt, J P P ^b  

^a Medisch Spectrum Twente   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPYRRONIUM BROMIDE; PLACEBO;

AGED; ARTICLE; CAREGIVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERSALIVATION; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME; XEROSTOMIA;

EID: 77950927299     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d8c1b7     Document Type: Article

References (17)

1. Edwards LL, Quigley EM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease: frequency and patho-physiology. Neurology 1992;42:726-732.
2. Johnston BT, Li Q, Castell JA, Castell DO. Swallowing and esophageal function in Parkinson's disease. Am J Gas-troenterol 1995;90:1741-1746.
3. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician 2004;69:2628-2634.
4. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord 2002;8:277-284.
5. Praharaj SK, Arora M, Gandotra S. Clozapine-induced sialorrhea: pathophysiology and management strategies. Psy-chopharmacology (Berl) 2006;185:265-273.
6. Proulx M, De Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord 2005;20:204-207.
7. Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Be-narroch EE, Pazo JH. Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 2006;21:660-667.
8. Chou KL, Evatt M, Hinson V, Kompoliti K. Sialorrhea in Parkinson's disease: a review. Mov Disord 2007;22:2306-2313.
9. Merello M. Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management. Drugs Aging 2008;25:1007-1019.
10. Molloy L. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence. Curr Opin Neurol 2007;20:493-498.
11. Scanlon EF, Sener SF. Head and neck neoplasia following irradiation for benign conditions. Head Neck Surg 1981; 4:139-145.
12. Martin TJ, Conley SF. Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngol Head Neck Surg 2007; 137:54-58.
13. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Mo-ran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000;154:1214-1218.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neuro-surg Psychiatry 1992;55:181-184.
15. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134:657-662. (Pubitemid 32322244)
16. Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996;150:932-935.
17. Duggal HS. Glycopyrrolate for clozapine-induced sialorrhea. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1546-1547.